top of page
DERM2023 POSTERS
We invite you to view the DERM2023 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.
Poster 2
Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream within Adolescent Population Authors: Adelaide Hebert, MD;...
41 views
Poster 3
Comparison of Cutaneous Irritation with Repeated Application of Tazarotene 0.045% Lotion, Adapalene 0.3% Gel, and Trifarotene 0.005%...
29 views
Poster 4
Benefit of Topical Combination Therapy for Acne Treatment: Analysis of Effect Size Using Number Needed to Treat Authors: Steven R....
29 views
Poster 5
Advancement of Personalized Photopneumatic Therapy for Rapid, Visible Improvement in Patients with Mild-to-Moderate Acne Authors: Girish...
26 views
Poster 6
Long-Term Safety and Efficacy of Clascoterone Cream 1% in Patients ≥12 Years Old with Acne Vulgaris Authors: Lawrence F. Eichenfield,...
27 views
Poster 7
Long-Term Efficacy of Baricitinib in Alopecia Areata: 104-Week Results from BRAVE-AA1 and BRAVE-AA2 Authors: Maryanne Senna, Arash...
34 views
Poster 8
Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata from 2 Randomized Clinical Trials Over a Median of 1.6 Years...
26 views
Poster 9
Clinical Outcomes for Up-Titration with Baricitinib Therapy in Patients with Severe Alopecia Areata from BRAVE-AA1 and BRAVE-AA2 Authors:...
22 views
Poster 10
Baseline Distribution of Eyebrow and Eyelash Loss by Severity of Scalp Hair Loss in Phase 3 Trials of Baricitinib for Alopecia Areata...
19 views
Poster 11
Duration of Current Episode of Alopecia Areata (AA) Influences Prognosis During Treatment with Baricitinib in Patients with Severe AA...
21 views
Poster 12
Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) from the Phase 2 and Phase 3 ALLEGRO Clinical Trial...
34 views
Poster 13
Impact of Disease History on the Efficacy of Ritlecitinib in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3...
22 views
Poster 14
Efinaconazole in the Age of Antifungal Resistance Authors: Ahmed Gamal, Mohammed Elshaer, Lisa Long, Thomas S. McCormick, Boni Elewski,...
20 views
Poster 15
Tapinarof Cream 1% Once Daily for the Treatment of Extensive Atopic Dermatitis in Adolescents and Children: Outcomes from the 4-Week...
36 views
Poster 16
Improvement Across Signs and Symptoms of Atopic Dermatitis with Lebrikizumab Use: Results from Two Phase 3, Randomized, Double-Blinded,...
27 views
Poster 17
Lebrikizumab Does Not Impact Vaccine-Induced Immune Responses: Results from A Phase 3 Study in Adult Patients with Moderate-to-Severe...
84 views
Poster 18
Assessing Imputation Methods with the Lebrikizumab Clinical Trial Program Authors: April W. Armstrong, Jonathan I. Silverberg, Jacob P....
33 views
Poster 19
Efficacy of Lebrikizumab in Patients with Atopic Dermatitis and Atopic Comorbidities: Pooled Results From 2 Phase 3 Monotherapy...
25 views
Poster 20
Patients with Moderate-to-Severe Atopic Dermatitis Experience Heterogeneous Disease Course Phenotypes: Results of a Real-World Study in...
29 views
Poster 21
Comparison of Two OTC Itch Relief Products After Single Application Authors: Christine Emesiani, PharmD; Matthew Meckfessel, PhD; Thu...
26 views
Poster 22
A Retrospective Multi-Center Case Series of Real-World Tralokinumab Use in Dupilumab-Experienced Patients Authors: Edward I. Herman, MD,...
22 views
Poster 23
Long-Term Safety and Efficacy of Tralokinumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: An interim analysis of ECZTEND...
18 views
Poster 24
Real-World Patient Characteristics and Early Patient-Reported Outcomes in Adult Patients with Moderate-to-Severe Atopic Dermatitis...
18 views
Search by
Poster
Number
bottom of page